| Filed On | Filing |
|---|---|
| 16 Nov 2026 | 144 |
| 10 Nov 2026 |
Form 4: Jedrzejek David, SVP and General Counsel
Gave up 5,829 shares to cover exercise price or tax ($133K) · Sold 3,091 shares ($74.2K) |
| 10 Nov 2026 | 144 |
| 06 Nov 2026 |
Form 4: Alstead Troy, Director
Received 89 shares as a grant or award · Granted 318 Class B Common Stock |
| 06 Nov 2026 |
Form 4: Beraud Jill, Director
Received 57 shares as a grant or award · Granted 97 Class B Common Stock |
| 06 Nov 2026 |
Form 4: Garten Yael, Director
Received 163 shares as a grant or award |
| 06 Nov 2026 |
Form 4: Geballe Daniel W, Director
Received 137 shares as a grant or award |
| 06 Nov 2026 |
Form 4: Jones Jeffrey J Ii, Director
Received 71 shares as a grant or award |
| 06 Nov 2026 |
Form 4: Marberger David S, Director
Received 77 shares as a grant or award |
| 06 Nov 2026 |
Form 4: Ming Jenny J, Director
Received 57 shares as a grant or award · Granted 109 Class B Common Stock |
| 06 Nov 2026 |
Form 4: Patrick Artemis, Director
Received 72 shares as a grant or award |
| 06 Nov 2026 |
Form 4: Prime Joshua E, Director
Received 111 shares as a grant or award |
| 06 Nov 2026 |
Form 4: Gowans Jason, EVP and CDTO
Sold 3,494 shares ($83.4K) |
| 05 Nov 2026 | SCHEDULE 13G/A |
| 04 Nov 2026 |
Form 4: Vandemore John M, EVP and CFO
Received 264,805 shares as a grant or award · Granted 794,415 Stock Appreciation Rights |
| 04 Nov 2026 |
Form 3: Vandemore John M, EVP and CFO
No securities owned |
| 04 Nov 2026 | 144 |
| 30 Oct 2026 | SCHEDULE 13G |
| 30 Oct 2026 | SCHEDULE 13G |
| 15 Oct 2026 | SCHEDULE 13G/A |
Loading...